Dr. MedLaw: Patients With Conflicting Medical Needs
Q: I have a patient who needs a carpal tunnel release. My problem is that this procedure is most...
Read More
Author: Rebecca Shover
Novel Regimen May Avoid TME Surgery in Rectal Cancer
In patients with rectal cancer, neoadjuvant radiotherapy (RT) followed by atezolizumab and...
Read More
Black Women With SLE Have More Severe Disease & Poorer Outcomes
In Black women with SLE, symptom and treatment self-efficacy were inversely related to fatigue and...
Read More
Tips for Avoiding Medical Claim Denials & Getting Paid
Adhering to billing guidelines can be a frustrating and challenging task. Despite painstakingly...
Read More
Complete Treatment Response Benefits Patients With CSU
For patients with chronic spontaneous urticaria (CSU), disease management is strongly associated...
Read More
OPERA Trial Opts for Non-Surgical Treatment for Rectal Cancer
The 38-month follow-up data of the phase 3 OPERA trial showed that non-surgical treatment is...
Read More
Even With Delay, Surgery Improves Survival in Early NSCLC Versus Stereotactic Radiation
Surgery was superior to stereotactic radiation for early non-small cell lung cancer, even in the...
Read More
Fucoidan May Improve QOL in Patients With Rectal Cancer
A randomized trial investigating fucoidan in patients with locally advanced rectal cancer (LARC)...
Read More
IMbrave 151 Missed Primary Endpoint in Advanced BTC
Adding bevacizumab to atezolizumab plus cisplatin and gemcitabine did not significantly improve...
Read More
Novel Fc-enhanced CTLA-4 Inhibitor Scores in Colorectal Cancer
The combination therapy of botensilimab plus balstilimab resulted in encouraging anti-tumor...
Read More
New Standard of Care for Colorectal Cancer
The phase 3 SUNLIGHT trial demonstrated that bevacizumab plus trifluridine/tipiracil (FTD/TPI)...
Read More
SWOG 1815, First-Ever Phase 3 Trial in BTC, Fails
The triplet regimen of nab-paclitaxel plus gemcitabine plus cisplatin (GCN) did not improve the...
Read More
Sorafenib Plus TACE May Control HCC After Resection
The postoperative adjuvant combination therapy of sorafenib plus transarterial chemoembolization...
Read More
Nanvuranlat Prolongs PFS in Refractory Advanced BTC
Patients with pre-treated, advanced biliary tract cancer (BTC) may benefit from treatment with...
Read More
New First-Line Option for Metastatic Pancreatic Duct Cancer
The phase 3 NAPOLI-3 trial showed that liposomal irinotecan plus 5-fluorouracil/leucovorin and...
Read More
Zolbetuximab Plus mFOLFOX6 Scores in Gastric Cancer
Zolbetuximab added to mFOLFOX6 improved the progression-free survival (PFS) and overall survival...
Read More
Identify Actionable & Achievable Dietary Goals With 9 Questions
High-quality nutrition and diet are important factors when managing patients with or at risk for...
Read More
Contemporary Pharmacotherapy for NTM Infections
Pharmacotherapy for NTM disease often involves antimycobacterials in combination with bronchial...
Read More